AMYE LILLJEDAHL: Open Payments
NPI 1174855183 · BELLVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 35 payments from 10 companies in 2025. Trend: 2023 $749 · 2024 $672 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $183 |
| AstraZeneca Pharmaceuticals LP | 8 | $138 |
| Amgen Inc. | 3 | $57 |
| Axsome Therapeutics, Inc. | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Exact Sciences Corporation | 2 | $37 |
| Boston Scientific Corporation | 1 | $27 |
| Dexcom, Inc. | 1 | $25 |
| Corcept Therapeutics | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $16 |
Products named: VRAYLAR, AIRSUPRA, OTEZLA, Auvelity, FARXIGA, TRINTELLIX, Cologuard Collection Kit, WaveWriter Alpha Prime 16.
Industry payments across TX — which companies pay providers there.
